Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fidia Spa ( (IT:FDA) ) just unveiled an announcement.
Fidia has advanced its financing strategy by issuing the eighth tranche of its convertible cum warrant bond loan reserved for Global Growth Holding Limited, placing 25 bonds worth a nominal €250,000 and attaching 25 million new warrants exercisable at €0.01 per share. These instruments are part of a broader capital structure plan that provides GGHL with significant potential equity exposure while supplying Fidia with fresh resources to support its industrial operations and growth.
The company also converted four bonds from this tranche into 13,333,333 new shares at a conversion price of €0.003, increasing its share capital by €40,000 to €11,637,761.90 and bringing the total number of shares outstanding to 179,411,972. With a total of €2 million now subscribed under the POC and further bonds and warrants still outstanding, Fidia continues to strengthen its capital base, a move that dilutes existing shareholders but reinforces funding for its positioning in the numerical control and high-speed milling markets.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a specialist in high-performance integrated milling systems and numerical control technology. The company serves primarily the mould sector for the automotive industry and the aerospace sector, offering solutions that cover the full milling process, including numerical controls, high-speed milling machines and CAM software for complex shapes.
Average Trading Volume: 3,832,471
Technical Sentiment Signal: Strong Sell
Current Market Cap: €500.4K
See more data about FDA stock on TipRanks’ Stock Analysis page.